First ASCO. First year of residency.
Grateful to have two first-author abstracts accepted, one poster presentation, and five additional abstracts as a co-author at this year’s ASCO Annual Meeting.
the evolving role of immunotherapy and advanced radiation techniques in managing complex malignancies.
I am thankful for the opportunity to present this work and for the mentorship and encouragement that helped bring it to fruition.
immunotherapy, but he also underwent MR-guided SBRT targeting the IVC tumor thrombus. Follow-up imaging demonstrated significant regression of both the primary liver tumor and the IVC tumor thrombus.
This case highlights the impact of multidisciplinary collaboration and
We’re thrilled that both our adult and pediatric stem cell/bone marrow transplant programs earned the highest possible +1 score in the 2025 @CIBMTR Survival Report — exceeding expected 1-year survival nationwide. Thank you to our dedicated team and partners for advancing patient care every day. Learn more: https://t.co/BMbN681I8i
It’s not #ASH25 without an award show…
Presenting the Multiple Myeloma Golden Globules 🏆🩸-
voted on by absolutely no one except a budding-lymphoma doc😊 and a qualified myeloma doc🙌🏾 (both running on caffeine and #ASH adrenaline) 😅
#ASHDailyNews
https://t.co/JkLEeBR36a
Yesterday’s Plenary highlighted important new insights into the biology of DLBCL in African American patients. Catch our full coverage — including key data and expert quotes — in today’s #ASHNewsDaily. #ASH25
https://t.co/XmS7FlPAZz
It was a great experience working and learning from this dream team! Special shoutout to the excellent ASH Staffs that made everything seamless!
#ASH25
Still energized after my first @AmCollegeGastro meeting. A truly enriching learning experience and a great chance to reconnect with peers and mentors in GI. Proud to have received the #ACG2025 Outstanding Poster Presenter Award. Grateful to @OBHBrookdaleIM for the steady support.